Oxford University Innovation is the University of Oxford's technology transfer company and manages the University's intellectual property portfolio, working with University researchers on identifying, protecting and marketing technologies through licensing, spin-out company formation and material sales. Oxford University Innovation also manages Oxford University Consulting, which arranges consulting services providing clients access to the expertise of the University's academics. Oxford University’s overarching Strategic Plan begins, “The University of Oxford aims to lead the world in research and education” immediately followed by, “They seek to do this in ways which benefit society on a national and a global scale.” Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Their role is to help University staff and students bring the benefits of their research and expertise to create impact in wider society. They support Oxford’s researchers, staff and students, offering commercial skills and a range of specialist resources in order to maximise research impact. Income is shared with those involved according to the University’s Regulations.

MEI Pharma is a oncology company focused on the clinical development of novel therapies for cancer. The Company’s clinical development pipeline includes lead drug candidate Pracinostat, a potential best-in-class, oral histone deacetylase (HDAC) inhibitor. Pracinostat has been tested in more than 150 patients in multiple Phase I and exploratory Phase II clinical trials, including advanced hematologic malignancies such as myelodysplastic syndrome, acute myeloid leukemia and myelofibrosis. The Company expects to initiate a randomized Phase II trial of Pracinostat in combination with standard-of-care in at least one hematologic malignancy toward the middle of 2013. In addition, MEI Pharma is developing two drug candidates derived from its isoflavone-based technology platform, ME-143 and ME-344. Results from a Phase I trial of intravenous ME-143 in heavily treated patients with solid refractory tumors were presented at the American Society of Clinical Oncology Annual Meeting in June 2012. A Phase I clinical trial of intravenous ME-344 in patients with solid refractory tumors is ongoing.

MDS Nordion, Inc. use to export medical isotopes, radio therapeutics and related technologies. Its products and services were used in hospitals, clinics, large medical supply companies, biotechnology, pharmaceutical companies, food processors and manufacturers. The company was founded in 1946 and was headquartered in Ottawa, Canada.

Argenx BV, a subsidiary of argenx SE, is a company headquartered in Belgium. The firm develops antibody ecosystems.

The Company has collaborated with M.D. Anderson Cancer Center in Houston, Texas; Massachusetts Institute of Technology in Cambridge, Massachusetts; and Rhode Island Hospital/Brown University in Providence, Rhode Island where teams of researchers are continuing advances on the Company's core technologies.

OptoTrace Technologies, Inc. develops trace chemical detection systems. It focuses on scientific research, manufacturing, application development services. The company was founded by Hong Wang and Xindi Wu in 2003 and is headquartered in Mountain View, CA.

Imperial Innovations is a technology commercialization and venture capital investor that focuses on technology. Imperial Innovations no longer invests in startups and now functions as the technology-transfer office of Imperial College. Imperial Innovations is focused on commercialising leading UK academic research sourced from the 'golden triangle' formed between Cambridge, Oxford and London. We are a technology commercialisation company that combines the activities of technology transfer, intellectual property protection and licensing, company incubation and investment. Innovations is focused on commercialising the most promising UK academic research across a broad range of technology sectors, and has developed particular expertise in: therapeutics, medtech, engineering and materials and information communication technology.

Volatile Analysis Corp. provides laboratory services. It specializes in volatile chemical detection and measurement for medical and industrial purposes. The firms services include analytical testing laboratory, odor, aroma consulting., sensory, litigation support and training services. The company was founded by Kathy Malmay-Bazemore and Russell Bazemore in March 2007 and is headquartered in Grant, AL.

Shandong Labo Biotechnology Co., Ltd., established on 2005-05-13, The scope of business includes the production of medical devices,Sales;Disinfectant production(Free of Hazardous Chemicals);Disinfectant sales(Free of Hazardous Chemicals);glassware,Office Supplies,Sales of Electronics;Import and export(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval);Medical Device Repair,Leasing and technical consulting services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The Academic Medical Center (Dutch: Academisch Medisch Centrum), or AMC, is the university hospital affiliated with the Universiteit van Amsterdam (University of Amsterdam). It is one of the largest and leading hospitals of The Netherlands, located in the Bijlmer neighborhood in the most south-eastern part of the city. AMC consistently ranks among the top 50 medical schools in the world.

Hypros is the world's leading high-tech enterprise in precision medical and genetic big data. The company is committed to integrating cutting-edge emerging technologies such as liquid biopsy, gene sequencing, artificial intelligence, and big data. It focuses on the whole process of diagnosis and treatment of cancer patients, and is determined to use technology to improve the quality of life and make every life healthy for 120 years. Hypros has completed the multi-center globalization of Shenzhen R&D Headquarters, Third-Party Medical Laboratory, GMP Production Workshop, US R&D Center, Hypus Genome Center and Shangrao International Precision Medical Health Industrial Park. The company invested hundreds of millions of dollars to introduce the world's most advanced Illumina NovaSeq6000, HiSeq X Ten, NextSeq500/550 series sequencing platform and digital PCR platform, successfully built the world's top genetic testing center. At present, the company's sequencing throughput is the second in the world, and the output of tumor gene data ranks in the forefront of the country. The business covers 300+ top three hospitals in more than 30 provinces.

MeiraGTx Netherlands BV operates as a biopharmaceutical company developing local gene therapy for inflammatory diseases. It is into develop adeno-associated viral mediated gene therapy for patients with rheumatic conditions. The company was founded in 2005 and is headquartered in Amsterdam, the Netherlands.

Shaanxi Lifegen Co., Ltd. is a company headquartered in China that provides drug genetic testing services.

Loxbridge is a private firm which finds disruptive innovations in healthcare technologies, founds start-up companies, and funds their development through to an investment-ready stage for other investors and strategic partners. Loxbridge aims to be at the forefront of enabling growth and success across innovations in science, medicine and technology, to meet a global healthcare need. Loxbridge supports an eclectic portfolio of growth stage companies that utilise a novel technology or approach, and enables them to become commercially successful investments.

Guangdong Optomedic Technology Co. Ltd. (doing business as Optomedic) is a company headquartered in Guangdong, China. The firm develops and manufactures medical devices. It was founded in 2013 by An Xin.

Rui Qu Biotechnology (Shanghai) Co., Ltd., established on 2007-04-05, Business scope includes research and development of new biomedical drugs,API,Biological health products,bio cosmetics,Pharmaceutical intermediates and diagnostic reagents,Transfer of self-research results,Provide relevant technical consulting services,Wholesale of biological cosmetics,import and export,Provide related supporting services(Commodities that do not involve state trade management,Quota involved,of license-managed goods,Apply in accordance with relevant national regulations). [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Guangzhou Medical Soft Intelligent Technology Co., Ltd., established on 2008-03-17, The business scope includes retailing of electronic products;Information Electronic Technology Services;software wholesale;software development;computer technology development,Technical Services;Commodity retail trade(Except for licensed and approved products);Information Technology Consulting Services;electronic,Communication and Automatic Control Technology Research,to develop;Computer and Auxiliary Equipment Repair;Conference and Exhibition Services;Commodity wholesale trade(Except for licensed and approved products);Wholesale of computer spare parts;Special Equipment Repair;Data processing and storage product design;Internet of things technology research and development;Technical development and technical service of digital medical imaging software;Technical development and technical services of medical imaging data transmission equipment;Licensed medical device business(apply<Medical device operating enterprise license>medical device",Including the third class of medical devices and need to apply<Medical device operating enterprise license>Class II medical devices that can only be operated);Production of medical electronic equipment(The specific production range is<Medical Device Manufacturing Enterprise License>prevail);medical diagnosis,Monitoring and treatment equipment manufacturing;

Flowmetric Life Sciences, Inc. provides Flow Cytometry Solutions in Precision Medicine. The company was founded by Renold Capocasale and is headquartered in Doylestown, PA.

Taizhou Hehe Biotechnology Co., Ltd., established on 2019-08-08, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Health Consulting Services(Does not include medical services);Cosmetics Retail;Cosmetics Wholesale(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:food business;Drug Wholesale;Drug retail;Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Guizhou Tanqi Big Data Technology Co., Ltd., established on 2021-06-30, Business scope includes legal,regulations,Those prohibited by the State Council's decision shall not operate;law,regulations,The State Council has decided to allow(approval)of,After approval by the examination and approval authority(approval)file management;law,regulations,The State Council has decided that a license is not required(approval)of,Market entities independently choose to operate.(Application software development;software development;Big data service;Artificial intelligence application software development;Artificial intelligence public data platform;Artificial intelligence basic resources and technology platform;Information Technology Consulting Services;Software outsourcing service;Artificial intelligence theory and algorithm software development;Anime Game Development;Network technology service;Artificial intelligence basic software development;(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments))